Article

EyeCon 2022: A sneak peek at MIGS updates with Dr Singh

This glaucoma session will offer a look at how to incorporate pearls into clinical practice.

This December, Ophthalmology Times® EyeCon 2022 will gather the nation’s leading ophthalmologists to share new data and practical strategies that clinicians can apply to their patients. The conference will take place December 16 to 17 at the JW Marriott Marco Island Beach Resort in Florida.

From imaging technology to novel agents, attendees will learn key insights that will keep their practices current in the coming year. The 2-day event will be chaired by Peter J. McDonnell, MD, director and William Holland Wilmer Professor of Ophthalmology at the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland; and Oluwatosin U. Smith, MD, a glaucoma specialist at Glaucoma Associates of Texas in Dallas.

Ahead of this year’s meeting, faculty member Inder Paul Singh, MD, spoke with Ophthalmology Times®’ Group Editorial Director Sheryl Stevenson about his upcoming presentation, as well as what he is looking forward to most and why this year’s event is a “must-attend” meeting. Singh is president of The Eye Centers of Racine and Kenosha, in Racine, Wisconsin.

To learn more about or to register for Ophthalmology Times® EyeCon 2022, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
© 2025 MJH Life Sciences

All rights reserved.